TRIB
Trinity Biotech plc
$1.20
+$0.01(+0.42%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$22.36M
Volume
146.10K
52W Range
$0.48 - $3.44
Target Price
$15.00
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $99.1M | $97.0M | $90.4M | $102.0M | $93.0M | $74.8M | $56.8M | ||
| Total Revenue | $99.1M | $97.0M | $90.4M | $102.0M | $93.0M | $74.8M | $56.8M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $-57.3M | $-55.6M | $-52.3M | $-53.4M | $-54.9M | $52.7M | $37.4M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $41.9M | $41.4M | $38.1M | $48.6M | $38.1M | $22.0M | $19.4M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $37.9M | $34.8M | $44.6M | $32.6M | $36.3M | $33.3M | $35.5M | ||
| Research & Development | $5.7M | $5.4M | $11.9M | $5.1M | $4.5M | $4.1M | $4.4M | ||
| Research Expense | $5.7M | $5.4M | $5.3M | $5.1M | $4.5M | $4.1M | $4.4M | ||
| Selling, General & Administrative | $32.2M | $29.5M | $27.7M | $26.4M | $24.7M | $29.2M | $31.2M | ||
| Selling & Marketing Expenses | $32.2M | $29.5M | $27.7M | $26.4M | $24.7M | $29.2M | $31.2M | ||
| General & Administrative Expenses | $-37.4M | $-38.0M | $-36.3M | $-33.3M | -- | $-28.8M | -- | ||
| Salaries & Wages | $-30.1M | $-30.9M | $5.0M | $1.1M | -- | $-28.0M | -- | ||
| Depreciation & Amortization | $-528.0K | $-79.0K | $-4.0K | $-40.0K | $-39.0K | $-2.3M | -- | ||
| Depreciation & Amortization | $-528.0K | $-79.0K | $-4.0K | $-40.0K | $-39.0K | $-1.4M | -- | ||
| Amortization | $-3.3M | $-2.8M | $-2.4M | $-1.4M | $-917.0K | $-923.0K | -- | ||
| Other Operating Expenses | -- | -- | -- | -- | $7.1M | -- | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $4.0M | $6.6M | $-6.5M | $16.0M | $1.8M | $-11.3M | $-16.1M | ||
| EBITDA | $-40.1M | $-24.1M | $-31.7M | $-4.2M | $2.8M | $-40.2M | $-24.1M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $-5.4M | $-5.1M | $-6.6M | $-643.0K | $-648.0K | $-1.3M | $11.1M | ||
| Interest Income Operating | $100.0K | -- | -- | -- | -- | $343.0K | -- | ||
| Intinc | $3.2M | $2.1M | $697.0K | $36.0K | $1.2M | $303.0K | $1.2M | ||
| Net Non-Operating Interest Income/Expense | $3.2M | $2.1M | $697.0K | $36.0K | $1.2M | $303.0K | $-9.9M | ||
| Gain on Sale of Securities | -- | -- | $91.0K | -- | -- | -- | -- | ||
| Other Income/Expense | $-45.4M | $-102.0K | $-91.0K | $4.9M | $-4.7M | $-91.4M | $11.0M | ||
| Other Special Charges | $15.7M | $102.0K | $33.6M | $9.9M | -- | $86.7M | $141.0K | ||
| SPECIAL ITEMS | |||||||||
| Restructring And Mn A Income | -- | -- | -- | $-388.0K | -- | $-274.0K | -- | ||
| Special Income Charges | $-47.2M | $-32.0M | $-24.3M | $-17.8M | $-6.9M | $-30.6M | -- | ||
| Impairment of Capital Assets | $41.8M | $26.9M | $24.3M | $17.8M | $6.9M | $5.8M | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-45.3M | $-28.3M | $-36.6M | $-7.3M | $103.0K | $-42.5M | $-25.9M | ||
| Pre-Tax Income | $-39.9M | $-23.2M | $-30.0M | $-6.6M | $751.0K | $-41.2M | $-36.9M | ||
| INCOME TAX | |||||||||
| Tax Provision | $-1.2M | $-525.0K | $-1.0M | $-620.0K | $-178.0K | $-192.0K | $-59.0K | ||
| NET INCOME | |||||||||
| Net Income | $-40.3M | $-22.1M | $-28.9M | $-6.4M | $875.0K | $-41.0M | $-24.0M | ||
| Net Income (Continuing Operations) | $-40.3M | $-22.1M | $-28.9M | $-6.4M | $875.0K | $-41.0M | $-36.9M | ||
| Net Income (Discontinued Operations) | $-40.3M | $-22.1M | $-28.9M | $-6.4M | $875.0K | $-41.0M | $-24.0M | ||
| Net Income (Common Stockholders) | $-40.3M | $-22.1M | $-28.9M | $-6.4M | $875.0K | $-41.0M | $-24.0M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-25.9M | ||
| TOTALS | |||||||||
| Total Expenses | $-19.3M | $-20.7M | $-7.7M | $-20.8M | $-18.6M | $86.0M | $72.9M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $86.5M | $83.6M | $83.6M | $83.6M | $83.6M | $134.9M | -- | ||
| Average Shares Outstanding (Diluted) | $17.3M | $16.7M | $16.7M | $16.4M | $17.5M | $27.0M | -- | ||
| Shares Outstanding | $96.2M | $96.2M | $83.6M | $83.6M | $83.6M | $152.4M | $18.6M | ||
| Basic EPS | $-2.33 | $-1.32 | $-1.73 | $-0.39 | $0.05 | $-1.52 | -- | ||
| Basic EPS (Continuing Operations) | $-2.24 | $-1.35 | $-1.74 | $-0.36 | $0.05 | $-1.52 | -- | ||
| Diluted EPS | $-2.33 | $-1.32 | $-1.73 | $-0.39 | $0.05 | $-1.52 | -- | ||
| Diluted EPS (Continuing Operations) | $-2.24 | $-1.35 | $-1.74 | $-0.36 | $0.05 | $-1.52 | -- | ||
| OTHER METRICS | |||||||||
| Depletion | $5.4M | -- | -- | -- | -- | -- | -- | ||
| Development Expense | -- | -- | $6.6M | -- | -- | -- | -- | ||
| Earnings from equity interest | $7.9M | $26.9M | $24.3M | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $7.9M | $26.9M | $24.3M | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | $102.0K | -- | $1.9M | $4.7M | -- | -- | ||
| Gain On Sale Of P P E | $3.0K | $15.0K | $17.0K | $30.0K | $-1.0K | $2.0K | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | $-1.6M | $568.0K | $77.0K | $-375.0K | $-54.0K | $-7.0K | -- | ||
| Net Income Discontinuous Operations | $-1.6M | $568.0K | $77.0K | $-375.0K | $-54.0K | $-7.0K | $12.8M | ||
| Non Recurring Operation Expense | -- | $5.1M | -- | -- | -- | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | -- | $37.4M | ||
| Other Gand A | $-37.4M | $-38.0M | $-36.3M | $-33.3M | -- | $-28.8M | -- | ||
| Other Impairment Of Capital Assets | $-29.7M | $-19.2M | $-16.6M | $6.8M | -- | $-4.6M | $11.1M | ||
| Realized Capital Gain | $100.0K | -- | $91.0K | -- | -- | -- | -- | ||
| Selling Expense | $32.2M | $29.5M | $27.7M | $26.4M | $24.7M | $29.2M | -- | ||
| Write Down | -- | -- | $6.6M | -- | -- | $24.7M | -- | ||
| Othspecchg | $5.4M | -- | -- | $6.8M | -- | -- | -- | ||
| Restruct | -- | -- | -- | $-388.0K | -- | $-274.0K | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRIB | $1.20 | +0.4% | 146.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |